Literature DB >> 16695344

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL.

W T Longcope1, J A Luetscher, M M Wintrobe, V Jäger.   

Abstract

Entities:  

Year:  1946        PMID： 16695344      PMCID： PMC435590          DOI： 10.1172/JCI101734

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  BAL (BRITISH ANTI-LEWISITE).

Authors:  L L Waters; C Stock
Journal:  Science       Date:  1945-12-14       Impact factor: 47.728

2.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

3.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION.

Authors:  J A Luetscher; H Eagle; W T Longcope; E B Watson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

4.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN.

Authors:  W Modell; H Gold; M Cattell
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808
  4 in total
  6 in total

1.  Deficiency Patterns in Metallic Poisoning.

Authors:  W Hughes
Journal:  Br Med J       Date:  1950-03-18

2.  Bal in the Treatment of Gold Toxicity.

Authors:  J G Macleod
Journal:  Ann Rheum Dis       Date:  1948       Impact factor: 19.103

3.  British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council.

Authors:  R A PETERS; J BENNET
Journal:  Br Med J       Date:  1947-10-04

4.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

5.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION.

Authors:  J A Luetscher; H Eagle; W T Longcope; E B Watson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

6.  Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).

Authors:  A B CARLETON; R A PETERS
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.